About ORTHOCON
ORTHOCON is a company based in Irvington (United States) founded in 2005 was acquired by Abyrx in April 2013. ORTHOCON has raised $27.16 million across 2 funding rounds from investors including Canaan, Abyrx and BB Biotech Ventures. ORTHOCON offers products and services including Hemostatic Bone Putty, MONTAGE, and Water-Soluble Hemostatic Bone Putty. ORTHOCON operates in a competitive market with competitors including Stryker, Zimmer Biomet, Humacyte, Smith & Nephew and NuVasive, among others.
- Headquarter Irvington, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Abyrx, Inc.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of ORTHOCON
ORTHOCON offers a comprehensive portfolio of products and services, including Hemostatic Bone Putty, MONTAGE, and Water-Soluble Hemostatic Bone Putty.
Provides hemostasis for bone surfaces during surgical procedures.
Settable putty that adheres to bleeding bone in surgical applications.
Hemostatic solution for easy application in bone surgery.
Funding Insights of ORTHOCON
ORTHOCON has successfully raised a total of $27.16M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $2.16 million completed in September 2010. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in ORTHOCON
ORTHOCON has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include Canaan, Abyrx and BB Biotech Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Canaan is recognized as an early-stage venture capital firm.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for ORTHOCON
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by ORTHOCON
Investment portfolio details for ORTHOCON
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - ORTHOCON
Detailed financials for ORTHOCON
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Orthocon Comparisons
Peer comparison for ORTHOCON
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of ORTHOCON
ORTHOCON operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Stryker, Zimmer Biomet, Humacyte, Smith & Nephew and NuVasive, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
3D-printed orthopedic products are manufactured for medical applications.
|
|
| Locked | Locked | Locked |
Medical devices for multiple health purposes are manufactured.
|
|
| Locked | Locked | Locked |
Human tissue-based products are developed for vascular disease applications.
|
|
| Locked | Locked | Locked |
Manufacturer of knee, hip and shoulder joint replacements
|
|
| Locked | Locked | Locked |
Smart surgical devices for spinal surgery are developed.
|
|
| Locked | Locked | Locked |
Developer of devices for spine surgery
|
Detailed competitors of ORTHOCON
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Orthocon
Complete news archive for ORTHOCON
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ORTHOCON
ORTHOCON was founded in 2005 and raised its 1st funding round 4 years after it was founded.
ORTHOCON is headquartered in Irvington, United States. It is registered at Irvington, New Jersey, United States.
ORTHOCON is a funded company, having raised a total of $27.16M across 2 funding rounds to date.
Orthocon was founded in 2005 and is based in Irvington, United States. Operations focus on medical therapeutics within the orthopaedic and spine surgery sectors. Resorbable products, including the FDA-approved HEMASORB Bone Hemostat Matrix, are created to address active bone bleeding. This synthetic matrix is applied directly to sites and is substantially resorbed within 30 days, supporting surgical procedures.
ORTHOCON offers Hemostatic Bone Putty, MONTAGE, and Water-Soluble Hemostatic Bone Putty.